Lv13
10 积分 2023-10-12 加入
Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC‐0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor
1小时前
待确认
New Means and Challenges in the Targeting of BTK
1天前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
2天前
已完结
Cyanide Trapping of Iminium Ion Reactive Metabolites: Implications for Clinical Hepatotoxicity
6天前
已完结
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
14天前
已完结
Remibrutinib, a Novel Bruton Tyrosine Kinase Inhibitor, Exhibits Improved Target Selectivity and Potency in Vitro
14天前
已完结
GPCR drug discovery: new agents, targets and indications
22天前
已完结
Disproportionately Increasing Incidence of Inflammatory Bowel Disease in Female Patients and the Elderly: An Update Analysis from the Global Burden of Disease Study 2021
30天前
已完结
Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms
30天前
已完结
Harnessing alternative splicing for off-the-shelf mRNA neoantigen vaccines in hepatocellular carcinoma
1个月前
已完结
皖公网安备34019202002308
